مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
Click here for full text options
LibKey Link

مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655Test
Australian and New Zealand Journal of Obstetrics and Gynaecology
Click here for full text options
LibKey Link

مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
LibKey Link

مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655Test
Australian and New Zealand Journal of Obstetrics and Gynaecology
LibKey Link

مصطلحات الفهرس: apixaban/dt [Drug Therapy], activated partial thromboplastin time, adult, aged, assay, controlled study, correlational study, drug effect, drug sensitivity, ex vivo study, female, human, letter, major clinical study, male, priority journal, prothrombin time, validation study, venous thromboembolism/dt [Drug Therapy], chromogenic anti factor Xa assay, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35436Test
International Journal of Laboratory Hematology
Click here for full text options
LibKey Link

مصطلحات الفهرس: apixaban/dt [Drug Therapy], activated partial thromboplastin time, adult, aged, assay, controlled study, correlational study, drug effect, drug sensitivity, ex vivo study, female, human, letter, major clinical study, male, priority journal, prothrombin time, validation study, venous thromboembolism/dt [Drug Therapy], chromogenic anti factor Xa assay, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35436Test
International Journal of Laboratory Hematology
LibKey Link

مصطلحات الفهرس: thrombophilia, venous thromboembolism/dt [Drug Therapy], apixaban/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], fish oil, rivaroxaban/dt [Drug Therapy], rivaroxaban/pv [Special Situation for Pharmacovigilance], warfarin/pv [Special Situation for Pharmacovigilance], human, adult, aged, all cause mortality, anticoagulant therapy, article, bleeding, body mass, clinical outcome, cohort analysis, deep vein thrombosis, female, follow up, hospital readmission, jugular vein thrombosis, major clinical study, male, menorrhagia, outcome assessment, portal vein thrombosis, priority journal, prospective study, recurrent disease, thrombocyte aggregation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36187Test
Seminars in Thrombosis and Hemostasis
Click here for full text options
LibKey Link

مصطلحات الفهرس: injury, lung embolism, major clinical study, male, malignant neoplasm, menorrhagia, moderate renal impairment, obese patient, obesity, postoperative hemorrhage, postpartum hemorrhage, priority journal, recurrent disease, retrospective study, risk factor, venous thromboembolism/dt [Drug Therapy], blood clotting factor 10a/ec [Endogenous Compound], enoxaparin/dt [Drug Therapy], enoxaparin/pv [Special Situation for Pharmacovigilance], clinically relevant nonmajor bleeding, clinical outcome, adult, aged, aging, anticoagulant therapy, article, bleeding, body weight, comorbidity, deep vein thrombosis, drug dose reduction, drug safety, estimated glomerular filtration rate, female, hematoma, human, infection, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36191Test
Seminars in Thrombosis and Hemostasis
Click here for full text options
LibKey Link

مصطلحات الفهرس: recurrence risk, risk factor, surgical thrombectomy, symptom, treatment duration, venous thromboembolism/di [Diagnosis], venous thromboembolism/dt [Drug Therapy], ventilation-perfusion scan, anticoagulant agent/do [Drug Dose], anticoagulant agent/dt [Drug Therapy], anticoagulant agent/po [Oral Drug Administration], apixaban/dt [Drug Therapy], apixaban/po [Oral Drug Administration], blood clotting factor 10a inhibitor/dt [Drug Therapy], D dimer/ec [Endogenous Compound], dabigatran/dt [Drug Therapy], dabigatran/po [Oral Drug Administration], dalteparin/dt [Drug Therapy], dalteparin/sc [Subcutaneous Drug Administration], edoxaban/dt [Drug Therapy], edoxaban/po [Oral Drug Administration], enoxaparin/dt [Drug Therapy], enoxaparin/sc [Subcutaneous Drug Administration], fibrinolytic agent/dt [Drug Therapy], rivaroxaban/dt [Drug Therapy], rivaroxaban/po [Oral Drug Administration], compression stocking, warfarin/dt [Drug Therapy], access to information, antiphospholipid syndrome, article, Australia and New Zealand, computer assisted tomography, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], deep vein thrombosis/th [Therapy], Doppler ultrasonography, human, incidence, Internet, low drug dose, lung angiography, lung embolism/di [Diagnosis], lung embolism/dt [Drug Therapy], lung embolism/su [Surgery], lung embolism/th [Therapy], malignant neoplasm, medical society, percutaneous thrombectomy, practice guideline, prescription, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35318Test
Medical Journal of Australia
Click here for full text options
LibKey Link

مصطلحات الفهرس: thrombophilia, venous thromboembolism/dt [Drug Therapy], apixaban/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], fish oil, rivaroxaban/dt [Drug Therapy], rivaroxaban/pv [Special Situation for Pharmacovigilance], warfarin/pv [Special Situation for Pharmacovigilance], human, adult, aged, all cause mortality, anticoagulant therapy, article, bleeding, body mass, clinical outcome, cohort analysis, deep vein thrombosis, female, follow up, hospital readmission, jugular vein thrombosis, major clinical study, male, menorrhagia, outcome assessment, portal vein thrombosis, priority journal, prospective study, recurrent disease, thrombocyte aggregation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36187Test
Seminars in Thrombosis and Hemostasis
LibKey Link